LAGUNA HILLS, Calif., March 5, 2007 (PRIME NEWSWIRE) (PRIMEZONE) -- Laguna Hills-based Alacrity Biosciences, Inc., a biopharmaceutical company focused on ophthalmic diseases, announced today it has completed a private financing with gross proceeds of approximately $8.45 million in a convertible note financing. Paramount BioCapital, Inc. served as the placement agent. Alacrity Biosciences was founded by Paramount BioSciences, LLC.
